Twelve healthy rats were divided into the T-2 toxin group receiving gavage of 1 mg/kg T-2 toxin and the control group receiving gavage of normal saline. Total relative concentrations of T-2 toxin and HT-2 toxin in the...Twelve healthy rats were divided into the T-2 toxin group receiving gavage of 1 mg/kg T-2 toxin and the control group receiving gavage of normal saline. Total relative concentrations of T-2 toxin and HT-2 toxin in the skeletal system（thighbone, knee joints, and costal cartilage） were significantly higher than those in the heart, liver, and kidneys（P 〈 0.05）. The relative concentrations of T-2 toxin and HT-2 toxin in the skeletal system（thighbone and costal cartilage） were also significantly higher than those in the heart, liver, and kidneys. The rats administered T-2 toxin showed rapid metabolism compared with that in rats administered HT-2 toxin, and the metabolic conversion rates in the different tissues were 68.20%-90.70%.展开更多
T-2 toxin,an omnipresent environmental contaminant,poses a serious risk to the health of humans and animals due to its pronounced cardiotoxicity.This study aimed to elucidate the molecular mechanism of cardiac tissue ...T-2 toxin,an omnipresent environmental contaminant,poses a serious risk to the health of humans and animals due to its pronounced cardiotoxicity.This study aimed to elucidate the molecular mechanism of cardiac tissue damage by T-2 toxin.Twenty-four male Sprague-Dawley rats were orally administered T-2 toxin through gavage for 12 weeks at the dose of 0,10,and 100 nanograms per gram body weight per day(ng/(g·day)),respectively.Morphological,pathological,and ultrastructural alterations in cardiac tissue were meticulously examined.Non-targeted metabolomics analysis was employed to analyze alterations in cardiac metabolites.The expression of the Sirt3/FoxO3α/MnSOD signaling pathway and the level of oxidative stress markers were detected.The results showed that exposure to T-2 toxin elicited myocardial tissue disorders,interstitial hemorrhage,capillary dilation,and fibrotic damage.Mitochondria were markedly impaired,including swelling,fusion,matrix degradation,and membrane damage.Metabonomics analysis unveiled that T-2 toxin could cause alterations in cardiacmetabolic profiles as well as in the Sirt3/FoxO3α/MnSOD signaling pathway.T-2 toxin could inhibit the expressions of the signaling pathway and elevate the level of oxidative stress.In conclusion,the T-2 toxin probably induces cardiac fibrotic impairment by affecting amino acid and choline metabolism as well as up-regulating oxidative stress mediated by the Sirt3/FoxO3α/MnSOD signaling pathway.This study is expected to provide targets for preventing and treating T-2 toxin-induced cardiac fibrotic injury.展开更多
目的:探讨甲基化酶抑制剂5'-氮杂-2'-脱氧胞苷(5'-Aza-2'-deoxycytidine,5'-Aza-CdR)对结直肠癌细胞株HT-29和LoVo中CDX2基因甲基化水平、mRNA及蛋白表达的影响.方法:用不同浓度5'-Aza-CdR处理结直肠癌细胞株HT...目的:探讨甲基化酶抑制剂5'-氮杂-2'-脱氧胞苷(5'-Aza-2'-deoxycytidine,5'-Aza-CdR)对结直肠癌细胞株HT-29和LoVo中CDX2基因甲基化水平、mRNA及蛋白表达的影响.方法:用不同浓度5'-Aza-CdR处理结直肠癌细胞株HT-29和LoVo.应用TaqMan探针为基础的实时定量PCR(Methylight)方法、SYBR Green PCR方法及蛋白印迹实验(Western blot)检测药物处理前后HT-29和LoVo细胞中CDX2基因的甲基化状态、mRNA和蛋白表达.结果:Methylight检测HT-29和LoVo细胞中C D X2蛋白在药物作用异常甲基化未得到逆转;实时荧光定量PCR和Western blot检测到0.5、1.0、1.5μmol/L 5'-Aza-CdR处理后C D X2基因m R N A和蛋白重新表达,实时荧光定量PCR检测对照组和不同浓度实验组在HT-29细胞株mRNA相对表达量分别为1.000±0.000、0.973±0.024、1.014±0.019和1.094±0.020;在LoVo细胞株相对表达量分别为1.000±0.000、0.966±0.038、1.050±0.029和1.007±0.019.Western blot检测CDX2蛋白在对照组和不同浓度实验组中HT-29细胞株相对表达量分别为0.454±0.049、0.501±0.041、0.340±0.050和0.531±0.046;LoVo细胞株相对表达量分别为0.527±0.037、0.415±0.037、0.432±0.040和0.626±0.046.以上作用无时间、剂量依赖性,但CDX2基因mRNA在HT-29细胞株表达(F=25.146,P=0.000)和LoVo细胞株表达(F=5.470,P=0.024)具有统计学差异,C D X2蛋白表达在HT-29细胞株表达(F=9.700,P=0.005)和LoVo细胞株表达(F=17.701,P=0.001)亦具有统计学差异.结论:结直肠癌细胞株HT-29和LoVo中CDX2基因mRNA和蛋白表达不受中DNA甲基化的表观遗传修饰的调控.展开更多
基金partially supported by National Natural Scientific Foundation of China[81620108026,81302393]
文摘Twelve healthy rats were divided into the T-2 toxin group receiving gavage of 1 mg/kg T-2 toxin and the control group receiving gavage of normal saline. Total relative concentrations of T-2 toxin and HT-2 toxin in the skeletal system（thighbone, knee joints, and costal cartilage） were significantly higher than those in the heart, liver, and kidneys（P 〈 0.05）. The relative concentrations of T-2 toxin and HT-2 toxin in the skeletal system（thighbone and costal cartilage） were also significantly higher than those in the heart, liver, and kidneys. The rats administered T-2 toxin showed rapid metabolism compared with that in rats administered HT-2 toxin, and the metabolic conversion rates in the different tissues were 68.20%-90.70%.
基金supported by the National Natural Science Foundation of China(No.81872567).
文摘T-2 toxin,an omnipresent environmental contaminant,poses a serious risk to the health of humans and animals due to its pronounced cardiotoxicity.This study aimed to elucidate the molecular mechanism of cardiac tissue damage by T-2 toxin.Twenty-four male Sprague-Dawley rats were orally administered T-2 toxin through gavage for 12 weeks at the dose of 0,10,and 100 nanograms per gram body weight per day(ng/(g·day)),respectively.Morphological,pathological,and ultrastructural alterations in cardiac tissue were meticulously examined.Non-targeted metabolomics analysis was employed to analyze alterations in cardiac metabolites.The expression of the Sirt3/FoxO3α/MnSOD signaling pathway and the level of oxidative stress markers were detected.The results showed that exposure to T-2 toxin elicited myocardial tissue disorders,interstitial hemorrhage,capillary dilation,and fibrotic damage.Mitochondria were markedly impaired,including swelling,fusion,matrix degradation,and membrane damage.Metabonomics analysis unveiled that T-2 toxin could cause alterations in cardiacmetabolic profiles as well as in the Sirt3/FoxO3α/MnSOD signaling pathway.T-2 toxin could inhibit the expressions of the signaling pathway and elevate the level of oxidative stress.In conclusion,the T-2 toxin probably induces cardiac fibrotic impairment by affecting amino acid and choline metabolism as well as up-regulating oxidative stress mediated by the Sirt3/FoxO3α/MnSOD signaling pathway.This study is expected to provide targets for preventing and treating T-2 toxin-induced cardiac fibrotic injury.
文摘目的:探讨甲基化酶抑制剂5'-氮杂-2'-脱氧胞苷(5'-Aza-2'-deoxycytidine,5'-Aza-CdR)对结直肠癌细胞株HT-29和LoVo中CDX2基因甲基化水平、mRNA及蛋白表达的影响.方法:用不同浓度5'-Aza-CdR处理结直肠癌细胞株HT-29和LoVo.应用TaqMan探针为基础的实时定量PCR(Methylight)方法、SYBR Green PCR方法及蛋白印迹实验(Western blot)检测药物处理前后HT-29和LoVo细胞中CDX2基因的甲基化状态、mRNA和蛋白表达.结果:Methylight检测HT-29和LoVo细胞中C D X2蛋白在药物作用异常甲基化未得到逆转;实时荧光定量PCR和Western blot检测到0.5、1.0、1.5μmol/L 5'-Aza-CdR处理后C D X2基因m R N A和蛋白重新表达,实时荧光定量PCR检测对照组和不同浓度实验组在HT-29细胞株mRNA相对表达量分别为1.000±0.000、0.973±0.024、1.014±0.019和1.094±0.020;在LoVo细胞株相对表达量分别为1.000±0.000、0.966±0.038、1.050±0.029和1.007±0.019.Western blot检测CDX2蛋白在对照组和不同浓度实验组中HT-29细胞株相对表达量分别为0.454±0.049、0.501±0.041、0.340±0.050和0.531±0.046;LoVo细胞株相对表达量分别为0.527±0.037、0.415±0.037、0.432±0.040和0.626±0.046.以上作用无时间、剂量依赖性,但CDX2基因mRNA在HT-29细胞株表达(F=25.146,P=0.000)和LoVo细胞株表达(F=5.470,P=0.024)具有统计学差异,C D X2蛋白表达在HT-29细胞株表达(F=9.700,P=0.005)和LoVo细胞株表达(F=17.701,P=0.001)亦具有统计学差异.结论:结直肠癌细胞株HT-29和LoVo中CDX2基因mRNA和蛋白表达不受中DNA甲基化的表观遗传修饰的调控.
